Research Bundle (Tesamorelin, Ipamorelin, BPC-157, TB-500)
Original price was: $285.00.$275.00Current price is: $275.00.
Bundle contains two individual lyophilized vials: Tesamorelin & Ipamorelin Blend (10mg/3mg) and the BPC-157 & TB-500 Blend (10mg/10mg). Third-party HPLC-MS verified, 99% purity. For research use only. Not for human use or consumption.
Bundle Contents
| Included Product | Vial Size | Individual Value |
|---|---|---|
| Tesamorelin & Ipamorelin Blend | 10mg / 3mg | $140.00 |
| BPC-157 / TB-500 Blend | 10mg / 10mg | $145.00 |
This bundle includes two individual peptide blend vials at a discounted price.
Legal Disclaimer: The bundle (Tesamorelin & Ipamorelin Blend, BPC-157 & TB-500 Blend) is sold by Protide Health for laboratory research purposes only. These products are not approved by the FDA for human consumption, medical use, or veterinary use. By completing a purchase, you verify that you are a qualified researcher and must comply with applicable local, state, and federal regulations. Please review our Terms & Conditions before purchasing.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Related products
AOD-9604
$60.00
BPC-157
Price range: $65.00 through $195.00
Cagrilintide
Price range: $95.00 through $155.00
DSIP
$100.00
Reviews
There are no reviews yet.